Insider · CIK 0001781982

Ellison Mark Jason Heath

Reports to the SEC for 1 company · SANTA MONICA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001781982

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−10.8K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+2,000 sh	—	—	2,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−7,200 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−8,250 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−7,015 sh	$20.00	−$140K	11,736
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−11.7K sh	$20.00	−$235K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−9,680 sh	$20.00	−$194K	0
2023-01-27	OPIANT PHARMACEUTICALS, INC.S Sale	Chief Development Officer	SSale	−610 sh	$20.26	−$12.4K	18,751
2023-01-09	OPIANT PHARMACEUTICALS, INC.S Sale	Chief Development Officer	SSale	−469 sh	$20.20	−$9,473.8	19,361
2023-01-05	OPIANT PHARMACEUTICALS, INC.S Sale	Chief Development Officer	SSale	−1,806 sh	$20.20	−$36.5K	19,830
2022-06-27	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+2,000 sh	—	—	21,636
2022-01-04	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+12K sh	—	—	19,636
2021-01-26	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+5,400 sh	—	—	7,636
2021-01-26	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Chief Development Officer	AAward	+10.8K sh	—	—	10,750
2021-01-26	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+2,236 sh	—	—	2,236
2020-01-07	OPIANT PHARMACEUTICALS, INC.Common StockA Award	Chief Development Officer	AAward	+8,250 sh	—	—	8,250
2020-01-07	OPIANT PHARMACEUTICALS, INC.A Award	Chief Development Officer	AAward	+4,150 sh	—	—	9,680
2019-07-29	OPIANT PHARMACEUTICALS, INC.Common StockM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−30K sh	—	—	0
2019-07-29	OPIANT PHARMACEUTICALS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−24.5K sh	$12.26	−$300K	5,530
2019-07-29	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+30K sh	$10.00	+$300K	30,000

Recent filings

Accepted (ET)
Mar 34
Ellison Mark Jason Heath0001385508-23-000067
SEC(opens sec.gov)
Jan 314
Ellison Mark Jason Heath0001385508-23-000033
SEC(opens sec.gov)
Jan 94
Ellison Mark Jason Heath0001385508-23-000022
SEC(opens sec.gov)
Jan 54
Ellison Mark Jason Heath0001385508-23-000013
SEC(opens sec.gov)
Jun 294
Ellison Mark Jason Heath0001385508-22-000104
SEC(opens sec.gov)
Jan 54
Ellison Mark Jason Heath0001385508-22-000011
SEC(opens sec.gov)
Jan 274
Ellison Mark Jason Heath0001385508-21-000015
SEC(opens sec.gov)
Jan 94
Ellison Mark Jason Heath0001385508-20-000013
SEC(opens sec.gov)
Jul 304
Ellison Mark Jason Heath0001385508-19-000075
SEC(opens sec.gov)

Companies

OPIANT PHARMACEUTICALS, INC.Chief Development Officer

Address

201 SANTA MONICA BLVD

SANTA MONICA, CA, 90401